CRVL, US2210061097

CorVel announced CareMC integration as CorVel stock trades at 33.10x earnings

Published on 10/14/2026 at 07:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
The September 22 integration links managed care to Guidewire ClaimCenter. CorVel stock trades at 33.10x earnings versus a 24.10x sector multiple.

Product integration and financial calendar

  • CorVel announced the CareMC Accelerator for Guidewire ClaimCenter on September 22, 2026.
  • Revenue reached USD 260.00 million in the fiscal first quarter of 2027.
  • CorVel stock was last at USD 78.81 on Nasdaq on October 13, 2026 at 4:00 p.m. ET.
CRVL, US2210061097, Illustration mit AI erstellt.

CorVel (ISIN US2210061097) announced on September 22, 2026 that its CareMC Accelerator was available for Guidewire ClaimCenter, while its valuation stood at 33.10x earnings. GlobeNewswire described the product as a link between managed care services and insurers' claims workflows, while Yahoo Finance reported the earnings multiple on October 3, 2026.

CareMC adds workflow connectivity

The CareMC Accelerator supports direct access to CorVel managed care services, secure single sign-on, automated claim-data transfer and real-time status updates, according to GlobeNewswire. The integration is available through the Guidewire Marketplace and is designed for Guidewire Cloud.

The operating importance is practical rather than cosmetic: claims teams can initiate and coordinate managed care services inside an existing claims environment, reducing duplicate data entry and keeping recommendations visible during case handling. That gives CorVel a product-level route to deepen relationships with carriers and third-party administrators.

What does the valuation imply?

Yahoo Finance put CorVel's price-to-earnings ratio at 33.10x against 24.10x for the wider US healthcare industry on October 3, 2026. The premium is the key counterweight to the integration story because the stock price already reflects a higher earnings multiple than the sector comparison.

The same source cited a discounted cash flow value of USD 65.75 against a recent USD 75.47 share price. That valuation gap makes CareMC adoption and contract growth important markers for the market's willingness to support the premium.

Three dated company developments

On August 5, 2026, CorVel reported USD 260.00 million in revenue for the fiscal first quarter of 2027, according to GlobeNewswire. On September 22, 2026, the company announced the four-function CareMC integration. On September 30, 2026, CorVel vice president Jennifer Yoss acquired 36 shares through the employee stock purchase plan, as StockTitan reported.

Reporting date and Nasdaq price

ToAlpha lists November 3, 2026 as CorVel's next earnings date. CorVel was last at USD 78.81 on Nasdaq on October 13, 2026 at 4:00 p.m. ET, with a 52-week range of USD 44.83 to USD 79.43 and market capitalization of USD 4.0 billion.

CorVel stock facts

  • Company: CorVel Corporation
  • ISIN: US2210061097
  • Ticker: CRVL
  • Primary exchange: Nasdaq
  • Nasdaq price (as of October 13, 2026, 4:00 p.m. ET): USD 78.81
  • Market capitalization: USD 4.0 billion (as of October 13, 2026)
  • 52-week range: USD 44.83-79.43 (as of October 13, 2026)
  • Sector / Industry: Healthcare / Healthcare services
  • Next earnings date: November 3, 2026

Market context: Market report S&P 500.

More news and analyses on CorVel stock

Disclaimer...
en | US2210061097 | CRVL | boerse | 70319971 | bgmi